期刊文献+

冠心病合并糖尿病患者冠状动脉血管内超声特点分析 被引量:3

Analysis of intravascular ultrasound characteristics of coronary heart disease with diabetes mellitus
下载PDF
导出
摘要 目的分析冠心病合并糖尿病患者冠状动脉血管内超声影像特点。方法将冠心病患者141例依据是否合并糖尿病分为观察组(合并糖尿病)51例和对照组(无糖尿病)90例,所有患者均于冠脉造影检查后行血管内超声检查,利用血管内超声观察2组病变血管特征。结果观察组三支病变明显多于对照组,单支病变少于对照组,差异有统计学意义(P<0.05);2组双支病变发生率比较差异无统计学意义(P>0.05)。2组斑块类型比较差异无统计学意义(P>0.05)。观察组合并钙化比例高于对照组,病变血管最小管腔面积(MLA)明显小于对照组,斑块负荷(PB)大于对照组,差异均有统计学意义(P<0.05)。结论冠心病合并糖尿病患者病变血管MLA更小,钙化更常见,斑块负荷重,管腔狭窄更弥漫、更严重。 Objective To investigate the characteristics of intravascular ultrasound in patients of coronary heart disease complicated with.Methods After coronary angiography,141 patients with coronary heart disease were enrolled in this study,and divided into two groups,according to with or without diabetes mellitus,observation group(diabetes mellitus) 51 cases,control group(without diabetes mellitus) 90 cases,IVUS were applied in all patients.Results The three lesions of observation group were significantly more than control group,a single lesion was less than control group,the difference was statistically significant(P〈0.05).The incidence of double-vessel disease was similar(P〉0.05).There was no significant difference in plaque type between two groups(P〉0.05).The ratio of calcification in observation group was higher than that of control group,the MLA of lesion was significantly smaller than that of control group,the plaque load(PB) was higher than that of control group,the difference was statistically significant(P〈0.05).Conclusion Patients with coronary heart disease and diabetes mellitus has more severe coronary lesions,bigger PB and smaller MLA compared to patients without diabetes.
出处 《临床合理用药杂志》 2017年第13期10-12,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 冠心病 糖尿病 血管内超声 Coronary artery disease Diabetes Intravascular ultrasound
  • 相关文献

参考文献7

二级参考文献84

  • 1刘文娴,吕树铮,陈立颖,卢燕玲.高龄冠心病患者完全和不完全血运重建对疗效的影响[J].中国循环杂志,2004,19(3):172-174. 被引量:14
  • 2Dimopoulos K, Dudek D, Piscione F, et al.Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial[J] o Int J Cardiol, 2012, 154(3): 275-281.
  • 3Levine GN, Bates ER, Blankenship JC, et al. 2011ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. JACC, 2011, 58(24): e44-e122.
  • 4Antithrombotic Trialists' Collaboration. Collaborative meta-analysisy of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients[J]. BMJ, 2002, 324(7329): 71-86.
  • 5Piro M, Della Bona R, Abbate A, et al. Sex-related differences in myocardial remodeling[J]. JACC, 2010, 55(11): 1057-1065.
  • 6Andreotti F, Marchese N.Women and coronary disease[J]. Heart, 2008, 94(1): 108-116.
  • 7Wu C, Hann EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions[J]. JACC, 2006, 47(3): 654-660.
  • 8Berger JS, Petemen JL, Brown DL. Vascular disease burden and in-hospital outcomes among patients undergoing pereutaneous coronary intervention in New York State[J]. Circ Cardiovase Interv, 2009, 2(4): 317-322.
  • 9Boersma E, Harrington RA, Molitemo D J, et al. Platelet glycoprotein lI b/ma inhibitors in acute coronary syndromes a meta-analysis of all major randomised clinical trials[J]. Lancet, 2002, 359(9302): 189-198.
  • 10Mega JL, Braunwald E, Wiviott SD, et al. Rivaroxaban inpatients with a recent acute coronary syndrome[J]. N Engl J Med, 2012, 366(1): 9-19.

共引文献39

同被引文献14

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部